The scope was previously awarded Breakthrough Device Designation to get the device to market faster.
The single-use scope is wholly disposable. Duodenoscopes have multiple small and complicated parts that make reprocessing the scopes difficult. While the majority of scopes are properly reprocessed, some organizations have had cross-contamination issues from poorly reprocessed scopes. The FDA recently recommended health systems transition to using scopes with disposable parts or fully disposable scopes.
Boston Scientific will begin selling the devices in the first quarter of 2020.
More articles on surgery centers:
3 expert insights on ASC, health system joint ventures
ASC could be part of outpatient expansion in California innovation district
4 new joint-venture ASCs — November 2019
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.